文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

11,12-EET 增加门脉血流阻力,并可能在门静脉高压症的内皮功能障碍中发挥作用。

11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.

机构信息

Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35100 Padova, Italy.

出版信息

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):72-5. doi: 10.1016/j.prostaglandins.2011.08.002. Epub 2011 Aug 11.


DOI:10.1016/j.prostaglandins.2011.08.002
PMID:21856435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4540347/
Abstract

CYP450-dependent epoxyeicosatrienoic acids (EETs) are potent arterial vasodilators, while 20-hydroxyeicosatatraenoic acid (20-HETE) is a vasoconstrictor. We evaluated their role in the control of portal circulation in normal and cirrhotic (CCl(4) induced) isolated perfused rat liver. Phenylephrine (PE) and endothelin-1 (ET-1) increased portal perfusion pressure, as did arachidonic acid (AA), 20-HETE, and 11,12-EET. Inhibition of 20-HETE with 12,12-dibromododecenoic acid (DBDD) did not affect basal pressure nor the responses to PE, ET-1, or AA. However, inhibition of epoxygenase with miconazole caused a significant reduction in the response to ET-1 and to AA, without affecting neither basal pressure nor the response to PE. Hepatic vein EETs concentration increased in response to ET-1, and was increased in cirrhotic, compared to control, livers. 20HETE levels were non-measurable. Miconazole decreased portal perfusion pressure in cirrhotic livers. In conclusion, 20HETE and EETs increase portal resistance; EETs, but not 20-HETE, mediate in part the pressure response to ET-1 in the portal circulation and may be involved in pathophysiology of portal hypertension.

摘要

CYP450 依赖性环氧二十碳三烯酸 (EETs) 是强效的动脉血管舒张剂,而 20-羟二十碳四烯酸 (20-HETE) 则是血管收缩剂。我们评估了它们在正常和肝硬化(CCl4 诱导)离体灌注大鼠肝中对门脉循环控制的作用。苯肾上腺素 (PE) 和内皮素-1 (ET-1) 增加门脉灌注压,花生四烯酸 (AA)、20-HETE 和 11,12-EET 也是如此。用 12,12-二溴十二烯酸 (DBDD) 抑制 20-HETE 并不影响基础压力或对 PE、ET-1 或 AA 的反应。然而,用咪康唑抑制环氧合酶会导致对 ET-1 和 AA 的反应显著减少,而对基础压力或 PE 的反应没有影响。肝静脉 EETs 浓度在 ET-1 反应中增加,并且在肝硬化中比在对照组中增加。20-HETE 水平不可测量。咪康唑降低了肝硬化肝脏的门脉灌注压。总之,20-HETE 和 EETs 增加门脉阻力;EETs,但不是 20-HETE,部分介导了 ET-1 在门脉循环中的压力反应,可能参与了门脉高压的病理生理学。

相似文献

[1]
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.

Prostaglandins Other Lipid Mediat. 2011-8-11

[2]
Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.

Prostaglandins Other Lipid Mediat. 2003-10

[3]
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats.

Liver Int. 2011-3-21

[4]
Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.

Am J Physiol Gastrointest Liver Physiol. 2009-7

[5]
Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.

Pflugers Arch. 2008-6

[6]
Inhibition of epoxyeicosatrienoic acid production in rats with cirrhosis has beneficial effects on portal hypertension by reducing splanchnic vasodilation.

Hepatology. 2016-7-22

[7]
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.

Gastroenterology. 2007-2

[8]
Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats.

J Gastroenterol Hepatol. 1997-4

[9]
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension.

Prostaglandins Other Lipid Mediat. 2015-7

[10]
Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.

J Hepatol. 2010-9-25

引用本文的文献

[1]
The Synergistic and Opposing Roles of ω-Fatty Acid Hydroxylase () and ω-1 Fatty Acid Hydroxylase () in Chronic Liver Disease.

Genome Biol Mol Genet. 2024

[2]
Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies.

Int J Mol Sci. 2021-10-3

[3]
Metabolomic Signature as a Predictor of Liver Disease Events in Patients With HIV/HCV Coinfection.

J Infect Dis. 2020-11-13

[4]
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target.

Pharmaceutics. 2017-2-20

[5]
Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.

Prostaglandins Other Lipid Mediat. 2012-1-10

本文引用的文献

[1]
Vascular pharmacology of epoxyeicosatrienoic acids.

Adv Pharmacol. 2010

[2]
Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.

J Hepatol. 2010-6-1

[3]
Epoxyeicosatrienoic acids and endothelium-dependent responses.

Pflugers Arch. 2010-3-12

[4]
Arachidonic acid cytochrome P450 epoxygenase pathway.

J Lipid Res. 2009-4

[5]
Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.

FASEB J. 2008-12

[6]
Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers.

J Hepatol. 2007-8

[7]
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase.

Am J Physiol Heart Circ Physiol. 2006-10

[8]
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells.

J Biol Chem. 2004-8-27

[9]
Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension.

Curr Opin Nephrol Hypertens. 2004-3

[10]
Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers.

J Hepatol. 2003-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索